Get notified when DNTH files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: DNTH Dianthus Therapeutics, Inc. /DE/ 8-K

Dianthus raises $673.5M in public offering, selling 8.5M shares at $81 with full overallotment

Filed March 12, 2026 · Period ending March 10, 2026 · ~1 min read

Key Changes

  • high

    Company completed public offering of 7.3M shares at $81/share plus 402K pre-funded warrants, raising approximately $673.5M net of fees after underwriters exercised full 1.16M share overallotment option.

    Item 1.01, 8.01 verify on EDGAR →
  • high

    Offering represents approximately 8.5M shares total (including warrants), creating significant dilution for existing shareholders but substantially strengthening balance sheet with immediate capital infusion.

  • medium

    Strong institutional demand evidenced by underwriters exercising full overallotment option on March 11, one day after pricing, suggesting positive market reception at $81 price point.

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.

Partner

Trade DNTH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify